rivastigmine
Showing 1 - 25 of 134
Depressive Disorder Trial in Utrecht (Rivastigmine Transdermal Product, Sham)
Recruiting
- Depressive Disorder
- Rivastigmine Transdermal Product
- Sham
-
Utrecht, NetherlandsUMC Utrecht
Mar 2, 2023
Bioequivalence Trial in Erfurt (Rivastigmine twice-weekly 9,5 mg/24 h, Exelon® 9.5 mg/24 h)
Active, not recruiting
- Bioequivalence
- Rivastigmine twice-weekly 9,5 mg/24 h
- Exelon® 9.5 mg/24 h
-
Erfurt, Thuringia, GermanySocraTec R&D GmbH, Clinical Pharmacology Unit
May 22, 2023
Progressive Supranuclear Palsy (PSP) Trial in Marseille Cedex 5 (Rivastigmine, Placebo)
Active, not recruiting
- Progressive Supranuclear Palsy (PSP)
- Rivastigmine
- Placebo
-
Marseille Cedex 5, FranceService de Neurologie et Pathologie du Mouvement Hôpital de La T
Aug 22, 2022
Bioavailability Trial in Baltimore (Rivastigmine (RLD) transdermal patch, Rivastigmine (generic) transdermal patch)
Completed
- Bioavailability
- Rivastigmine (RLD) transdermal patch
- Rivastigmine (generic) transdermal patch
-
Baltimore, MarylandGeneral Clinical Research Center (GCRC) at the University of Mar
Apr 1, 2022
Alzheimer's Disease Trial in India (Rivastigmine)
Completed
- Alzheimer's Disease
- Rivastigmine
-
Bangalore, Karnataka, India
- +9 more
Jan 24, 2023
Bioequivalence Trial in Erfurt (RID-TDS 13.3 mg/24 h, Exelon® 13.3 mg/24 h)
Recruiting
- Bioequivalence
- RID-TDS 13.3 mg/24 h
- Exelon® 13.3 mg/24 h
-
Erfurt, Thüringen, GermanySocraTec R&D GmbH, Clinical Pharmacology Unit
May 2, 2023
Nutraceuticals and Drug Treatment in Frail Older Adults
Recruiting
- Frailty
- Nutraceuticals
-
Naples, It, ItalyPasquale Mone
May 4, 2022
Parkinson Disease, Parkinson Disease Dementia Trial in Baltimore (Rivastigmine transdermal patch)
Completed
- Parkinson Disease
- Parkinson Disease Dementia
- Rivastigmine transdermal patch
-
Baltimore, MarylandUniversity of Maryland School of Medicine, Dept. of Neurology
Jan 25, 2022
Alzheimer, CVA (Cerebrovascular Accident) Trial in Singapore (Rivastigmine)
Completed
- Alzheimer Disease
- CVA (Cerebrovascular Accident)
- Rivastigmine
-
Singapore, SingaporeNational Neuroscience Institute
Mar 3, 2021
Hallucinations, Auditory, Psychosis Trial in New Haven (Rivastigmine Transdermal Product, Scopolamine, Placebo)
Recruiting
- Hallucinations, Auditory
- Psychosis
- Rivastigmine Transdermal Product
- +2 more
-
New Haven, ConnecticutConnecticut Mental Health Center
Mar 2, 2022
Delirium Trial in Cairo (Rivastigmine Transdermal System [Exelon], Melatonin)
Completed
- Delirium
- Rivastigmine Transdermal System [Exelon]
- Melatonin
-
Cairo, Abassia, EgyptAin Shams University
Jul 8, 2020
Parkinson Disease Trial in United Kingdom (Rivastigmine Transdermal System, Placebo Transdermal System)
Recruiting
- Parkinson Disease
- Rivastigmine Transdermal System
- Placebo Transdermal System
-
Romford, Accepted, United Kingdom
- +26 more
Dec 22, 2021
Parkinson's Disease Trial in Portland (Strattera, Exelon, Placebo)
Completed
- Parkinson's Disease
- Strattera
- +2 more
-
Portland, OregonOregon Health & Science University
Jun 17, 2020
Healthy Trial in Oxford (Reboxetine, Rivastigmine, Placebo oral tablet)
Completed
- Healthy
- Reboxetine
- +2 more
-
Oxford, Oxfordshire, United KingdomDept of Psychiatry, University of Oxford
Jun 15, 2020
Bioequivalence Trial in Erfurt (RID-TDS 9.5 mg/24 h, Exelon® 9.5 mg/24 h)
Completed
- Bioequivalence
- RID-TDS 9.5 mg/24 h
- Exelon® 9.5 mg/24 h
-
Erfurt, Thüringen, GermanySocraTec R&D GmbH, Clinical Pharmacology Unit
Sep 18, 2019
Mild to Moderate Alzheimer's Disease Trial in Japan (Rivastigmine Patch)
Completed
- Mild to Moderate Alzheimer's Disease
- Rivastigmine Patch
-
Fukuoka city, Fukuoka, Japan
- +18 more
Aug 5, 2019
Dementia Trial in Porto (Treatment withdrawal)
Completed
- Dementia
- Treatment withdrawal
-
Porto, PortugalCentro Hospitalar Universitário de São João
Apr 4, 2022
Alzheimer Trial in Paris (Placebo, Masitinib (4.5), Standard of care)
Not yet recruiting
- Alzheimer Disease
- Placebo
- +2 more
-
Paris, FranceInstitut de la mémoire et Maladie d'Alzheimer, Hôpitaux Universi
Sep 29, 2022
Dementia, Cognitive Impairment, Mild Cognitive Impairment Trial in Bronx (5-Cog, Health Literacy & Grip Assessment)
Active, not recruiting
- Dementia
- +3 more
- 5-Cog
- Health Literacy & Grip Assessment
-
Bronx, New YorkAlbert Einstein College of Medicine
Dec 21, 2022
Dementia, Dementia, Vascular, Dementia With Lewy Bodies Trial in United States (Care Ecosystem)
Not yet recruiting
- Dementia
- +4 more
- Care Ecosystem
-
San Francisco, California
- +5 more
Dec 20, 2022
Alzheimer's Disease Trial (Thymatron IV device (Somatics))
Not yet recruiting
- Alzheimer's Disease
- Thymatron IV device (Somatics)
- (no location specified)
Apr 21, 2021
Diabetes in Elderly People With Dementia in France
Completed
- Alzheimer Disease
- Incidence analysis
-
Toulouse, FranceUniversity Hospital
Aug 31, 2021
Diabetes, Type 2 Trial in Easton (Donepezil 5-10 Mg Oral Tablet, Placebo Oral Tablet)
Recruiting
- Diabetes Mellitus, Type 2
- Donepezil 5-10 Mg Oral Tablet
- Placebo Oral Tablet
-
Easton, MarylandUniversity of Maryland Shore Regional Health
Oct 20, 2021
Alzheimer Trial in Canada (Montelukast buccal film, Placebo buccal film)
Recruiting
- Alzheimer Disease
- Montelukast buccal film
- Placebo buccal film
-
Victoria, British Columbia, Canada
- +12 more
Jul 21, 2022